Verdoorn, Todd A.
Merck & Co., Inc., Rahway, NJ, USA (United States) · Johnson & Johnson (United States) · Pfizer (United States) · Bristol-Myers Squibb (United States) · Intra Cellular Therapies (United States) · Vertex Pharmaceuticals (United States)
3 papers on CoChatORCID 0000-0002-3587-1602
Most cited papers
- Verified
A Family of AMPA-Selective Glutamate Receptors
Keinänen, K., Wisden, W., Sommer, B., Werner, P., Herb, A., Verdoorn, T. A., Sakmann, B., & Seeburg, P. H. (1990) · Science
Neuroscience and Neuropharmacology ResearchAmino Acid Enzymes and Metabolism
Cited by 1,479
- Verified
N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents
Lynch, D. R., Anegawa, N. J., Verdoorn, T., & Pritchett, D. B. (1994) · Molecular Pharmacology
Neuroscience and Neuropharmacology ResearchAmino Acid Enzymes and Metabolism
Cited by 173
- Verified
Dynamics of β-Amyloid Reductions in Brain, Cerebrospinal Fluid, and Plasma of β-Amyloid Precursor Protein Transgenic Mice Treated with a γ-Secretase Inhibitor
Barten, D. M., Guss, V. L., Corsa, J. A., Loo, A., Hansel, S. B., Zheng, M., Munoz, B., Srinivasan, K., Wang, B., Robertson, B. J., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 159
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free